-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Oral antiretroviral therapy for the prevention of HIV-1 infection: ready for prime-time?
Mark W Hull, Julio SG Montaner
Editorial: Clinical Investigation
-
Oral antiretroviral therapy for the prevention of HIV-1 infection: ready for prime-time?
Mark W Hull, Julio SG Montaner
Editorial: Clinical Investigation
-
Oral antiretroviral therapy for the prevention of HIV-1 infection: ready for prime-time?
Mark W Hull, Julio SG Montaner
Editorial: Clinical Investigation
-
Oral antiretroviral therapy for the prevention of HIV-1 infection: ready for prime-time?
Mark W Hull, Julio SG Montaner
Editorial: Clinical Investigation
-
Oral antiretroviral therapy for the prevention of HIV-1 infection: ready for prime-time?
Mark W Hull, Julio SG Montaner
Editorial: Clinical Investigation
-
Oral antiretroviral therapy for the prevention of HIV-1 infection: ready for prime-time?
Mark W Hull, Julio SG Montaner
Editorial: Clinical Investigation
-
Oral antiretroviral therapy for the prevention of HIV-1 infection: ready for prime-time?
Mark W Hull, Julio SG Montaner
Editorial: Clinical Investigation
-
Oral antiretroviral therapy for the prevention of HIV-1 infection: ready for prime-time?
Mark W Hull, Julio SG Montaner
Editorial: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation